
Sign up to save your podcasts
Or


This episode of IOL Radio features Dr Jason Levy, Interventional Radiologist at Northside Hospital in Atlanta, Georgia and lead investigator of the OPuS One trial. This trial studied the quality of life outcomes from a global, prospective, nonrandomized, multicenter study of radiofrequency ablation using Medtronic’s OsteoCool™ RF Ablation System for the palliative treatment of patients with painful osseous metastases. Dr Levy discusses the out-to-12-months outcomes he presented at the Society of Interventional Radiology (SIR) 2021 meeting.
By IOL RadioThis episode of IOL Radio features Dr Jason Levy, Interventional Radiologist at Northside Hospital in Atlanta, Georgia and lead investigator of the OPuS One trial. This trial studied the quality of life outcomes from a global, prospective, nonrandomized, multicenter study of radiofrequency ablation using Medtronic’s OsteoCool™ RF Ablation System for the palliative treatment of patients with painful osseous metastases. Dr Levy discusses the out-to-12-months outcomes he presented at the Society of Interventional Radiology (SIR) 2021 meeting.